| scholarly article | Q13442814 |
| P2093 | author name string | Danilo Carrozzino | |
| Piero Porcelli | |||
| P2860 | cites work | Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis | Q22251072 |
| Gut/brain axis and the microbiota | Q26998106 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Relationship between somatosensory amplification and alexithymia in a Japanese psychosomatic clinic | Q28212134 | ||
| The clinical application of the biopsychosocial model | Q28282208 | ||
| The Revised Toronto Alexithymia Scale: some reliability, validity, and normative data | Q30987943 | ||
| Deconstructing the sensation of pain: The influence of cognitive processes on pain perception | Q31140829 | ||
| Alexithymia and dermatology: the state of the art. | Q33378196 | ||
| Alexithymia: a facet of essential hypertension | Q33858839 | ||
| Recent developments in alexithymia theory and research | Q33878733 | ||
| Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions | Q34094755 | ||
| The assessment of alexithymia in medical settings: implications for understanding and treating health problems | Q34097571 | ||
| Alexithymia in cancer patients: review of the literature | Q34133691 | ||
| Gut feelings: the emerging biology of gut-brain communication | Q34199959 | ||
| Alexithymia in irritable bowel syndrome | Q34244523 | ||
| The Levels of Emotional Awareness Scale: a cognitive-developmental measure of emotion | Q34252655 | ||
| Overview: hypochondriasis, bodily complaints, and somatic styles | Q34256189 | ||
| Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement | Q34293132 | ||
| Alexithymia as a Moderator of Treatment Outcomes in a Randomized Controlled Trial on Brief Psychodynamic Interpersonal Psychotherapy for Patients with Multisomatoform Disorder. | Q54453329 | ||
| An exploratory study comparing psychological profiles and its congruence with clinical performance among patients with functional or motility digestive disorders | Q58854353 | ||
| Age is strongly associated with alexithymia in the general population | Q61911111 | ||
| Sounding board. The biopsychosocial model and medical education. Who are to be the teachers? | Q70294219 | ||
| Alexithymia in inflammatory bowel disease. A case-control study | Q71539117 | ||
| Alexithymia characteristics before and after living donor transplantation | Q73013110 | ||
| Alexithymia and functional gastrointestinal disorders. A comparison with inflammatory bowel disease | Q73071713 | ||
| "Paradoxical psychiatric syndrome" of the recipient after child-to-parent living-related liver transplantation | Q73587835 | ||
| The 20-Item Toronto Alexithymia Scale. III. Reliability and factorial validity in a community population | Q73837389 | ||
| Construct validity of rorschach variables for alexithymia | Q77149242 | ||
| Alexithymia, coping, and illness behavior correlates of pain experience in cancer patients | Q79342263 | ||
| Alexithymia in the German general population | Q81436799 | ||
| Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? | Q81638242 | ||
| The development of the Toronto Structured Interview for Alexithymia: item selection, factor structure, reliability and concurrent validity | Q81639707 | ||
| Alexithymia and functional gastrointestinal disorders (FGID) | Q83825781 | ||
| Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study | Q87473381 | ||
| The Severity of Symptoms Related to Irritable Bowel Syndrome is a Risk Factor for the Misclassification of Significant Organic Disease | Q87764816 | ||
| From the Lesson of George Engel to Current Knowledge: The Biopsychosocial Model 40 Years Later | Q50117317 | ||
| Management of Functional Somatic Syndromes and Bodily Distress | Q50147152 | ||
| Childhood Trauma and Functional Variants of 5-HTTLPR Are Independently Associated with Alexithymia in 5,283 Subjects from the General Population. | Q50147176 | ||
| The influence of alexithymia on persistent symptoms of dyspepsia after laparoscopic cholecystectomy | Q50188440 | ||
| Alexithymia and adult attachment representations: associations with the five-factor model of personality and perceived relationship adjustment. | Q50645517 | ||
| On the relationship between interoceptive awareness and alexithymia: is interoceptive awareness related to emotional awareness? | Q50648287 | ||
| Cortical activation in alexithymia as a response to emotional stimuli. | Q50876786 | ||
| An evaluation of the absolute and relative stability of alexithymia in women with breast cancer. | Q50898910 | ||
| The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. | Q50911973 | ||
| Alexithymia is associated with gastrointestinal symptoms, but does not predict endoscopy outcome in patients with gastrointestinal symptoms. | Q50940051 | ||
| The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. | Q50997548 | ||
| Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. | Q51017719 | ||
| Emotional eating, alexithymia, and binge-eating disorder in obese women. | Q51030596 | ||
| Intact physiological response to arousal with impaired emotional recognition in alexithymia. | Q51068980 | ||
| Is alexithymia a risk factor for unexplained physical symptoms in general medical outpatients? | Q51071531 | ||
| Pervasive emotion recognition deficit common to alexithymia and the repressive coping style. | Q51076413 | ||
| A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. | Q51108707 | ||
| Alexithymia as a risk factor for type 2 diabetes mellitus in the metabolic syndrome: a cross-sectional study. | Q51126221 | ||
| Construct validity of the Toronto Alexithymia Scale. | Q51192070 | ||
| Levels of emotional awareness: a cognitive-developmental theory and its application to psychopathology. | Q51201620 | ||
| Alexithymia. Theoretical considerations | Q51288440 | ||
| Physical illness, the individual and the coping processes. | Q51330405 | ||
| Assessment of alexithymia with the Rorschach Comprehensive System: the Rorschach Alexithymia Scale (RAS). | Q51855927 | ||
| The INSPIRE study: do personality traits predict general quality of life (Short form-36) in distressed patients with ulcerative colitis and Crohn's disease? | Q51886698 | ||
| Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorders. | Q51943499 | ||
| Association between pretransplant psychological assessments and posttransplant psychiatric disorders in living-related transplantation. | Q51958410 | ||
| Psychometric properties of the Observer Alexithymia Scale in a clinical sample. | Q51963527 | ||
| Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. | Q53249230 | ||
| Criterion-related validity of the diagnostic criteria for psychosomatic research for alexithymia in patients with functional gastrointestinal disorders. | Q53324748 | ||
| How are alexithymia and physical illness linked? A review and critique of pathways. | Q54219162 | ||
| Effect of Alexithymia and Emotional Repression on Postsurgical Pain in Women With Breast Cancer: A Prospective Longitudinal 12-Month Study | Q40421021 | ||
| Aspects of abnormal illness behaviour | Q40783632 | ||
| Coping with inner feelings and stress: heavy alcohol use in the context of alexithymia | Q41098981 | ||
| Alexithymia is linked to neurocognitive, psychological, neuroendocrine, and immune dysfunction in persons living with HIV. | Q42258149 | ||
| Alexithymia is associated with increased cardiovascular mortality in middle-aged Finnish men. | Q43233433 | ||
| Correlation between alexithymia and hypersensitivity to visceral stimulation in human | Q43345283 | ||
| The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease? | Q43407703 | ||
| Toward the development of a new self-report alexithymia scale | Q43450199 | ||
| Gastroesophageal reflux disease: alexithymia and attachment style | Q43922037 | ||
| Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. | Q44124963 | ||
| Increased pain sensitivity among adults reporting irritable bowel syndrome symptoms in a large population-based study | Q44255421 | ||
| Alexithymia and cancer pain: the effect of psychological intervention. | Q44437753 | ||
| Alexithymia in Chinese chronic obstructive pulmonary disease (COPD) patients: the prevalence and related factors of alexithymia | Q44748620 | ||
| Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study | Q45356128 | ||
| Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients | Q45720090 | ||
| Alexithymia in the medically ill. Analysis of 1190 patients in gastroenterology, cardiology, oncology and dermatology | Q45810575 | ||
| Psychosocial predictors of irritable bowel syndrome diagnosis and symptom severity. | Q45947737 | ||
| Alexithymia and somatization in general population | Q46046006 | ||
| Decreased immune response in alexithymic women: a cross-sectional study | Q46340754 | ||
| "Good" patients and "difficult" patients--rethinking our definitions | Q46521418 | ||
| A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach | Q46547153 | ||
| A randomized controlled trial of brief psychoanalytic psychotherapy in patients with functional dyspepsia. | Q46559386 | ||
| The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome | Q47363970 | ||
| Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome | Q47848938 | ||
| An Attachment-Based Model of the Relationship Between Childhood Adversity and Somatization in Children and Adults. | Q47855185 | ||
| Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C. | Q47879553 | ||
| The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial. | Q47930843 | ||
| Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis | Q47945856 | ||
| HPA system activity in alexithymia: a cortisol awakening response study. | Q48025110 | ||
| The role of alexithymia in quality of life impairment in patients with chronic hepatitis C during antiviral treatment | Q48039259 | ||
| Somatization symptoms or interferon-related adverse events? Alexithymia and somatization in somatic symptom reporting of patients with chronic hepatitis C. | Q48068545 | ||
| Genetic Associations of Alexithymia in Predicting Interferon-Induced Depression in Chronic Hepatitis C. | Q48069728 | ||
| Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying. | Q48071706 | ||
| Impaired self-awareness and theory of mind: an fMRI study of mentalizing in alexithymia | Q48487956 | ||
| Influence of alexithymia on health-related quality of life in inflammatory bowel disease: are there any related factors? | Q48488534 | ||
| Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension | Q48504041 | ||
| Temporal stability of alexithymia in cancer patients following a psychological intervention. | Q48554256 | ||
| Risk factors for impaired health-related quality of life in functional dyspepsia | Q48758947 | ||
| The role of psychiatric symptoms, alexithymia, and maladaptive defenses in patients with functional dyspepsia | Q48771930 | ||
| Alexithymia and tissue inflammation | Q48808327 | ||
| Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia | Q48925576 | ||
| Stability of alexithymia in the general population: an 11-year follow-up | Q48960982 | ||
| The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure | Q34337085 | ||
| Alexithymia and somatosensory amplification in functional dyspepsia. | Q34368294 | ||
| Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease | Q34465236 | ||
| Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review | Q34534079 | ||
| The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20. | Q35024688 | ||
| Alexithymia and somatisation: quantitative review of the literature | Q35119574 | ||
| The 20-Item Toronto Alexithymia Scale. IV. Reliability and factorial validity in different languages and cultures | Q35204596 | ||
| New trends in alexithymia research | Q35651247 | ||
| Effects of the Social Environment and Stress on Glucocorticoid Receptor Gene Methylation: A Systematic Review | Q35738712 | ||
| IBS and IBD - separate entities or on a spectrum? | Q36144375 | ||
| Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meetingROMEII criteria for irritable bowel syndrome | Q36308712 | ||
| Recent understanding of IBD pathogenesis: implications for future therapies | Q36639759 | ||
| Cultural models and somatic syndromes | Q37015169 | ||
| Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control | Q37123580 | ||
| Alexithymia and personality traits of patients with inflammatory bowel disease. | Q37620621 | ||
| Psychological factors in patients with peptic ulcerand functional dyspepsia | Q37711126 | ||
| Abdominal pain in Irritable Bowel Syndrome: A review of putative psychological, neural and neuro-immune mechanisms | Q37811371 | ||
| The unifying concept of illness behavior | Q38072202 | ||
| The overlap between IBS and IBD: what is it and what does it mean? | Q38177849 | ||
| Changes in alexithymia following psychological intervention: a review | Q38204880 | ||
| Pathways in gut-brain communication: evidence for distinct gut-to-brain and brain-to-gut syndromes. | Q38364774 | ||
| Epidemiology and risk factors for IBD. | Q38366954 | ||
| What Does the Word “Psychosomatic” Really Mean? A Historical and Semantic Inquiry | Q38495947 | ||
| Alexithymia and automatic processing of emotional stimuli: a systematic review | Q38768983 | ||
| Alexithymia and depression in the recovery of chronic pain patients: a follow-up study | Q38834801 | ||
| Alexithymia in Chronic Pain Disorders | Q38842228 | ||
| Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease | Q38950426 | ||
| Current Psychosomatic Practice | Q39018849 | ||
| Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study | Q39084768 | ||
| Somatization in Parkinson's Disease: A systematic review | Q39316546 | ||
| Anxiety in close relationships is higher and self-esteem lower in patients with irritable bowel syndrome compared to patients with inflammatory bowel disease | Q39502307 | ||
| The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study | Q39665748 | ||
| Alexithymia and its relationships with C-reactive protein and serum lipid levels among drug naïve adult outpatients with major depression. | Q40034739 | ||
| Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease | Q40049653 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroenterology | Q120569 |
| alexithymia | Q1129046 | ||
| P304 | page(s) | 470 | |
| P577 | publication date | 2018-04-06 | |
| P1433 | published in | Frontiers in Psychology | Q2794477 |
| P1476 | title | Alexithymia in Gastroenterology and Hepatology: A Systematic Review. | |
| P478 | volume | 9 |
| Q95268253 | Effects of Patients' Perceptions of Physician-Patient Relational Empathy on an Inflammation Marker in Patients with Crohn's Disease: The Intermediary Roles of Anxiety, Self-Efficacy, and Sleep Quality |
| Q93088091 | Emotional Suppression and Oneiric Expression in Psychosomatic Disorders: Early Manifestations in Emerging Adulthood and Young Patients |
Search more.